Widespread access to antiretroviral therapy has transformed human immunodeficiency virus from a rapidly fatal diagnosis into a manageable chronic illness. Consequently, clinicians worldwide now manage an expanding demographic of geriatric patients facing complex non-AIDS chronic diseases. Addressing aging with HIV comorbidities requires understanding whether the duration of HIV infection accelerates the onset of non-communicable illnesses. A newly published multicenter investigation from Canada provides vital clarity on this critical geriatric question.

Overview of the CHANGE HIV Cohort

Researchers evaluated data from 540 participants enrolled in the CHANGE HIV (Correlates of Healthy Aging in Geriatric HIV) study across seven primary and tertiary clinical centers in Canada. All participants were aged 65 years or older, with a median age of 69 years. In this cohort, 90% identified as male, 76% were white, and 92% maintained an undetectable viral load with a median CD4 count of 561 cells/mm³. Furthermore, participants exhibited significant multimorbidity, presenting with a median of three concurrent medical conditions. The investigators stratified participants into groups based on their cumulative duration of known HIV infection, evaluating those diagnosed less than 15 years, 15 to 29 years, and 30 or more years prior. Through comprehensive regression models, the authors accounted for demographic factors, viral suppression status, nadir immunologic markers, and individual lifestyle variables.

Cardiovascular, Pulmonary, and Renal Illnesses Across Cohorts

Historically, clinicians assumed that prolonged exposure to chronic inflammation would yield higher rates of cardiovascular, pulmonary, and renal disease over time. However, this study demonstrated that the prevalence of coronary artery disease, peripheral artery disease, and stroke did not differ between individuals with longer versus shorter durations of HIV infection. Similarly, rates of chronic kidney disease and chronic obstructive pulmonary disease remained comparable across all diagnostic duration tiers. Asthma and chronic liver diseases also exhibited equivalent distribution across the strata. Therefore, chronic exposure to treated HIV does not inevitably amplify all categories of age-related end-organ deterioration. Instead, traditional vascular risk factors and chronological aging appear to drive organ pathology in patients who survive to older age.

Specific Risks in Aging with HIV Comorbidities

Although many organ systems demonstrated comparable stability, specific clinical conditions showed a distinct association with a longer duration of HIV infection. After adjusting for multiple confounders, investigators found that individuals diagnosed with HIV for longer durations experienced higher rates of peripheral neuropathy, diabetes mellitus, and non-AIDS malignancies. In addition, peripheral neuropathy, dyslipidemia, and Kaposi's sarcoma occurred at younger ages relative to other diagnoses. Early antiretroviral regimens, particularly first-generation nucleoside reverse transcriptase inhibitors such as stavudine and didanosine, likely contributed to persistent mitochondrial damage and irreversible nerve injury. Similarly, cumulative metabolic stress, pancreatic lipotoxicity, and chronic immune activation over decades elevate the risk for glycemic dysregulation.

The Decisive Role of Modifiable Lifestyle Factors

Beyond duration of infection, the study underscored the profound influence of lifestyle factors on geriatric well-being. Cigarette smoking, recreational substance use, and poor nutritional intake emerged as robust independent drivers of multi-organ morbidity. In older adults living with HIV, tobacco exposure accelerates cardiovascular events and lung pathology far more aggressively than viral duration alone. In addition, physical inactivity exacerbates frailty, functional impairment, and musculoskeletal complaints like osteoarthritis. Consequently, healthcare providers must avoid attributing all clinical complications exclusively to viral history. Clinicians must actively prioritize smoking cessation counseling, dietary optimization, physical exercise prescriptions, and substance misuse mitigation during regular outpatient visits to preserve functional independence.

Optimizing Cancer Screening and Preventative Geriatric Care

Because the prevalence of non-AIDS malignancies and secondary cancers rose significantly with longer infection duration, comprehensive oncologic surveillance remains paramount. Clinicians should ensure strict adherence to standardized age-appropriate screenings, including mammography, colonoscopy, low-dose chest computed tomography, and cervical or anal cytology where indicated. Furthermore, managing polypharmacy presents an urgent priority in this population. Because geriatric patients take numerous non-HIV medications alongside antiretroviral drugs, providers must vigilantly monitor for cytochrome P450 interactions, renal clearance alterations, and anticholinergic burdens. Regular cognitive and fall assessments will also help maintain patient functional status and life quality.

Frequently Asked Questions

Does a longer duration of HIV infection automatically increase cardiovascular disease in older adults?

No, recent evidence indicates that the duration since an HIV diagnosis does not independently increase cardiovascular disease among adults aged 65 and older. Chronic vascular conditions such as coronary artery disease, peripheral artery disease, and stroke exhibit similar prevalence regardless of diagnosis timing. Therefore, traditional cardiovascular risk factors, including dyslipidemia, hypertension, smoking status, and chronological age, remain the primary drivers of cardiovascular events in this demographic.

Why do older patients with long-standing HIV experience more peripheral neuropathy?

Older individuals with prolonged HIV diagnoses frequently received older, first-generation antiretroviral medications, including stavudine, didanosine, or zalcitabine. These early antiretroviral drugs caused cumulative mitochondrial toxicity, axonal degeneration, and chronic peripheral nerve damage. Consequently, nerve injury persists for decades even after switching to modern, safer regimens, resulting in a substantially higher prevalence of symptomatic peripheral neuropathy among long-term HIV survivors.

How should physicians prioritize preventive healthcare for geriatric patients with HIV?

Physicians caring for older adults with HIV should prioritize aggressive lifestyle modification, metabolic management, and routine cancer surveillance. Clinicians must focus on smoking cessation, nutritional counseling, exercise promotion, and blood pressure and glycemic control. Furthermore, providers must carefully review all co-prescribed medications to minimize adverse drug-drug interactions and reduce polypharmacy, while maintaining strict adherence to age-appropriate oncologic screening protocols.

Disclaimer: This content is for informational and educational purposes only, and should not be taken as professional medical advice. Healthcare professionals should make clinical decisions based on their independent judgment and individual patient assessments. While we strive for accuracy, clinical guidelines and practice may vary. Refer to the latest local and national guidelines for clinical practice.

References

1. Zhabokritsky A et al. Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years. HIV Med. 2026 Oct 31. doi: 10.1111/hiv.70344. PMID: 42963988.
2. Guaraldi G, Palella FJ Jr. Clinical implications of aging with HIV infection: perspectives and the future. J Antimicrob Chemother. 2017;72(5):1297-1303.
3. Erlandson KM, Karris MY. HIV and aging: reconsidering the approach to comorbidities and geriatric syndromes. Clin Infect Dis. 2019;69(12):2218-2224.